Article
Clinical and preclinical therapeutic outcome metrics for USH2A-related disease.
Human molecular genetics - 21 Jul 2020
Toms Maria, Dubis Adam M, de Vrieze Erik, Tracey-White Dhani, Mitsios Andreas, Hayes Matthew, Broekman Sanne, Baxendale Sarah, Utoomprurkporn Nattawan, Bamiou Doris, Bitner-Glindzicz Maria, Webster Andrew R, Van Wijk Erwin, Moosajee Mariya
Abstract excerpt
USH2A variants are the most common cause of Usher syndrome type 2, characterized by congenital sensorineural hearing loss and retinitis pigmentosa (RP), and also contribute to autosomal recessive non-syndromic RP. Several treatment strategies are under development; however, sensitive clinical trial endpoint metrics to determine therapeutic efficacy have not been identified. In the present study, we have performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
